How ongoing care shapes GLP-1 outcomes 2x Longer on therapy Ongoing support keeps patients on GLP-1s 2x longer, maximizing long-term benefits 9+ Systems affected GLP-1s influence brain, heart, kidney, & more
Declare it, show documentation if asked, and move on
Patients must follow these guidelines carefully to ensure consistent outcomes
Weeks 1 through 4: 2 mg once weekly Weeks 5 through 8: 4 mg once weekly Weeks 9 through 12: 8 mg once weekly Weeks 13 and beyond: 8 to 12 mg once weekly (based on response and tolerance) This protocol reaches the therapeutic range in approximately 8 weeks
Some patients may experience symptoms such as nausea, vomiting, diarrhea, and constipation
Potential Role of Chronic Physical Exercise on Redox System Modulation: Implications on Vitiligo Development Vitiligo Patients have an associated high rate of inflammatory comorbidities such as MetS and cardiovascular diseases (Lotti and DErme, 2014)